Morgan Stanley’s Innovid Corp. CTV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-268,701
| Closed | -$830K | – | 8301 |
|
|
2024
Q4 | $830K | Sell |
268,701
-54,085
| -17% | -$128K | ﹤0.01% | 5178 |
|
|
2024
Q3 | $581K | Buy |
322,786
+175,006
| +118% | +$318K | ﹤0.01% | 5332 |
|
|
2024
Q2 | $273K | Sell |
147,780
-2,711
| -2% | -$5.81K | ﹤0.01% | 5544 |
|
|
2024
Q1 | $375K | Sell |
150,491
-40,549
| -21% | -$70.2K | ﹤0.01% | 5441 |
|
|
2023
Q4 | $287K | Buy |
191,040
+150,389
| +370% | +$192K | ﹤0.01% | 5814 |
|
|
2023
Q3 | $52K | Sell |
40,651
-18,209
| -31% | -$21.3K | ﹤0.01% | 6151 |
|
|
2023
Q2 | $64.2K | Sell |
58,860
-34,353
| -37% | -$35.7K | ﹤0.01% | 6122 |
|
|
2023
Q1 | $131K | Buy |
93,213
+10,644
| +13% | +$19.4K | ﹤0.01% | 5900 |
|
|
2022
Q4 | $141K | Buy |
82,569
+32,546
| +65% | +$88.2K | ﹤0.01% | 5817 |
|
|
2022
Q3 | $135K | Buy |
50,023
+10,673
| +27% | +$30.4K | ﹤0.01% | 5923 |
|
|
2022
Q2 | $65K | Buy |
39,350
+34,474
| +707% | +$148K | ﹤0.01% | 6493 |
|
|
2022
Q1 | $29K | Buy |
+4,876
| New | +$26.7K | ﹤0.01% | 6982 |
|
Morgan Stanley's CTV Position: Q1 2025 in Review
Morgan Stanley sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 268,701 shares — an estimated $830K sold.
Morgan Stanley first reported a position in CTV in Q1 2022 and held it in 12 quarters. The position peaked at $830K in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.
- Morgan Stanley reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
- Morgan Stanley sold 268,701 Innovid Corp. shares in Q1 2025, an estimated $830K.
- Morgan Stanley first reported a position in Innovid Corp. in Q1 2022 and held it in 12 quarters.
- Morgan Stanley's Innovid Corp. position peaked at $830K in Q4 2024.
- 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.